PhenixFIN Corp Files Q2 2024 10-Q Report

TL;DR

PhenixFIN Corp (formerly Medley Capital) dropped its Q2 10-Q. Check financials.

AI Summary

PhenixFIN Corporation filed its 10-Q for the quarterly period ended June 30, 2024. The company, formerly known as Medley Capital Corp, is incorporated in Delaware and headquartered in New York City. The filing details its financial performance and operations for the specified quarter.

Why It Matters

This filing provides investors with an update on PhenixFIN Corporation's financial health and operational performance during the second quarter of 2024, crucial for investment decisions.

Risk Assessment

Risk Level: low — This is a standard quarterly financial filing (10-Q) and does not inherently contain new, high-risk information.

Key Players & Entities

• PhenixFIN Corporation (company) — Registrant
• June 30, 2024 (date) — Quarterly Period End Date
• Medley Capital Corp (company) — Former Company Name
• Delaware (location) — State of Incorporation
• New York (location) — Principal Executive Offices City
• 445 Park Avenue, 10th Floor, New York, NY 10022 (address) — Principal Executive Offices Address
• 212-859-0390 (phone_number) — Registrant's Telephone Number

FAQ

Key Financial Figures

• $0.001 — ich registered Common Stock, par value $0.001 per share PFX The NASDAQ Global Market
• $271,114,372 — . The tax cost basis of investments is $271,114,372 as of June 30, 2024. The amortized cos
• $154,203,403 — 5) Percentage is based on net assets of $154,203,403 as of June 30, 2024. (6) Affiliated In

Filing Documents

• ea0210151-10q_phenixfin.htm (10-Q) — 2547KB
• ea021015101ex31-1_phenix.htm (EX-31.1) — 7KB
• ea021015101ex31-2_phenix.htm (EX-31.2) — 7KB
• ea021015101ex32-1_phenix.htm (EX-32.1) — 7KB
• 0001213900-24-065749.txt ( ) — 12977KB
• pfx-20240630.xsd (EX-101.SCH) — 137KB
• pfx-20240630_cal.xml (EX-101.CAL) — 47KB
• pfx-20240630_def.xml (EX-101.DEF) — 459KB
• pfx-20240630_lab.xml (EX-101.LAB) — 810KB
• pfx-20240630_pre.xml (EX-101.PRE) — 468KB
• ea0210151-10q_phenixfin_htm.xml (XML) — 2849KB

Financial Information

PART I. Financial Information

Financial Statements

Item 1. Financial Statements Consolidated Statements of Assets and Liabilities as of June 30, 2024 (unaudited) and September 30, 2023 1 Consolidated Statements of Operations for the three and nine months ended June 30, 2024 and 2023 (unaudited) 2 Consolidated Statements of Changes in Net Assets for the three and nine months ended June 30, 2024 and 2023 (unaudited) 3 Consolidated Statements of Cash Flows for the nine months ended June 30, 2024 and 2023 (unaudited) 4 Consolidated Schedules of Investments as of June 30, 2024 (unaudited) and September 30, 2023 5

Notes to Consolidated Financial Statements (unaudited)

Notes to Consolidated Financial Statements (unaudited) 20

Management's Discussion and Analysis of Financial Condition and Results of Operations

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations 44

Quantitative and Qualitative Disclosures About Market Risk

Item 3. Quantitative and Qualitative Disclosures About Market Risk 58

Controls and Procedures

Item 4. Controls and Procedures 59

Other Information

Part II. Other Information 60

Legal Proceedings

Item 1. Legal Proceedings 60

Risk Factors

Item 1A. Risk Factors 60

Unregistered Sales of Equity Securities and Use of Proceeds

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 76

Defaults Upon Senior Securities

Item 3. Defaults Upon Senior Securities 76

Mine Safety Disclosures

Item 4. Mine Safety Disclosures 76

Other Information

Item 5. Other Information 76

Exhibits

Item 6. Exhibits 76

SIGNATURES

SIGNATURES 78 i PHENIXFIN CORPORATION Consolidated Statements of Assets and Liabilities June 30, 2024 (Unaudited) September 30, 2023 Assets: Investments at fair value Non-controlled, non-affiliated investments (amortized cost of $ 152,515,155 and $ 134,339,121 respectively) $ 148,691,260 $ 125,531,031 Affiliated investments (amortized cost of $ 20,564,242 and $ 48,233,910 , respectively) 14,407,827 37,289,617 Controlled investments (amortized cost of $ 98,034,975 and $ 82,437,692 , respectively) 70,582,278 63,640,043 Total Investments at fair value 233,681,365 226,460,691 Cash and cash equivalents 8,866,519 5,988,223 Receivables: Interest receivable 1,715,284 971,115 Dividends receivable 215,705 161,479 Other receivable 205,984 31,425 Deferred financing costs 649,042 699,124 Due from Affiliate 451,178 409,214 Other assets 410,565 833,000 Prepaid share repurchase 101,115 199,019 Receivable for investments sold - 3,940,175 Total Assets $ 246,296,757 $ 239,693,465 Liabilities: Credit facility and notes payable (net of debt issuance costs of $ 1,439,916 and $ 1,688,835 , respectively) $ 85,294,535 $ 84,253,106 Payable for investments purchased 1,834,831 4,123,059 Accounts payable and accrued expenses 3,789,402 3,066,984 Interest and fees payable 520,057 690,398 Other liabilities 327,045 432,698 Administrator expenses payable (see Note 6) 143,936 - Due to Affiliate 183,548 - Deferred revenue - 421,685 Total Liabilities 92,093,354 92,987,930 Commitments and Contingencies (see Note 8) Net Assets: Common Shares, $ 0.001 par value; 5,000,000 shares authorized; 2,723,709 shares issued; 2,019,778 and 2,073,713 common shares outstanding, respectively 2,021 2,074 Capital in excess of par value 692,441,333 694,812,239 Total distributable earnings (loss) ( 538,239,951 ) ( 548,108,778 ) Total Net Assets 154,203,403 146,705,535 Total Liabilities and Net A

View Full Filing

View this 10-Q filing on SEC EDGAR